Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thymic epithelial tumor × Radiation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Glioblastoma 66 Prostatic Neoplasms 50 Breast Neoplasms 44 Esophageal Neoplasms 42 Carcinoma, Non-Small-Cell Lung 38 Rectal Neoplasms 35 Lung Neoplasms 32 Gliosarcoma 30 Head and Neck Neoplasms 28 Squamous Cell Carcinoma of Head and Neck 27 Pancreatic Neoplasms 24 Brain Neoplasms 24 Uterine Cervical Neoplasms 22 Neoplasm Metastasis 19 Glioma 18 Esophageal Squamous Cell Carcinoma 18 Neoplasms 17 Melanoma 17 Sarcoma 16 Oropharyngeal Neoplasms 15 Astrocytoma 14 Adenocarcinoma Of Esophagus 14 Carcinoma, Squamous Cell 12 Urinary Bladder Neoplasms 11 Stomach Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma, Follicular 9 Endometrial Neoplasms 9 Central Nervous System Neoplasms 9 Lymphoma, B-Cell, Marginal Zone 8

Interventions

toripalimab 1 pembrolizumab 1 apatinib 1 TP protocol 1 Surgical Procedures, Operative 1 Radiation 1 Drug Therapy 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03858582 2021-03-22

neoadjuvant_thymic Epithelial Tumor

Samsung Medical Center

Phase 2 Unknown

Thymic epithelial tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡